Effective patient advocacy in the Huntington's disease community involved more than raising awareness. Advocates achieved a regulatory reversal by directly engaging with lawmakers' offices, such as that of Senator Ron Johnson. This targeted political action was crucial in getting their concerns about the FDA's previous stance heard and ultimately changed.
A change in leadership at the FDA can completely alter the viability of a drug's approval. Unicure's gene therapy, previously stalled under former officials Marty Makkari and Vinay Prasad, found a clear path to submission after they departed. This demonstrates that the philosophies of individual regulators, not just established processes, can dictate a drug's future.
In 'one-and-done' gene therapy trials for progressive diseases, a sham surgery placebo doesn't just deny a patient treatment. It can also render them ineligible for any future clinical trials, effectively eliminating all hope for a cure. This ethical dilemma makes recruiting for such trials nearly impossible, as patients refuse to take that risk.
An anonymous senior FDA official's comment calling Unicure's treatment a "failed therapy" caused widespread anger, confusion, and distress within the Huntington's patient community. The statement, perceived as a lie, forced patient advocates to perform damage control and rebuild trust, highlighting the profound real-world impact of off-the-record government briefings.
While RFK Jr. is famous for his controversial vaccine stance, which is mired in legal battles, his changes to food and nutrition policy may have a more lasting impact. Efforts to reduce ultra-processed foods in federal dietary guidelines and school meals align with broader public health trends and are less likely to be reversed by future administrations.
In response to reports questioning his work ethic, HHS Secretary RFK Jr. claimed his activity could be verified on his public calendar. However, journalists confirmed no such public calendar exists, and multiple Freedom of Information Act (FOIA) requests for it have been denied. This reveals a significant gap between his claims of transparency and actual administrative practice.